Insider filing · PBYI
Alan H Auerbach
President and CEO
profile →
Puma Biotechnology, Inc.
PBYI · Healthcare · 6 filings in 24 months
ticker →
Alan H Auerbach sold $364K of Puma Biotechnology (PBYI)
Executed Jul 6, disclosed Jul 9, 2 days later.
Value, as filed
$364K
44,058 sh × $8.26
Executed
Jul 6
the trade date, as filed
Disclosed
Jul 9
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AAAlan H Auerbach (President and CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Puma Biotechnology, Inc. (PBYI). The largest single filing was $364K of PBYI (44,058 sh × $8.26, as filed), executed Jul 6.
The name
PBYIHealthcare · Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Alan H Auerbach in PBYI
PBYISALE
Puma Biotechnology, Inc.
$106K18,012 sh × $5.88
Exec Jan 7
Filed Jan 8 · 5:30 PM ET PBYISALE Puma Biotechnology, Inc. $107K
33,841 sh × $3.15
Exec Jan 2 2025
Filed Jan 3 2025 · 5:30 PM ET